Transfusion‐related adverse events in patients with restrictive or liberal transfusion strategy. An analysis of the MINT trial
Transfusionsbedingte unerwünschte Ereignisse bei Patient:innen mit restriktiver oder liberaler Transfusionsstrategie. Analyse der MINT-Studie
Transfusion · 2026-01 · 66 (1) · 84-93
DOI: 10.1111/trf.70006 ↗Auf einen Blick
Bei Erwachsenen mit Myokardinfarkt traten transfusionsbedingte unerwünschte Ereignisse unter einer liberalen Strategie häufiger auf als unter einer restriktiven Strategie. Schwere Ereignisse waren selten.
Fragestellung
Wie häufig sind transfusionsbedingte unerwünschte Ereignisse bei Erwachsenen mit Myokardinfarkt unter restriktiver versus liberaler Transfusionsstrategie?
Methode
Analyse der MINT-Studie; klinische Zentren berichteten TRAE; Vergleich restriktive vs. liberale Transfusionsstrategie.
Ergebnisse
9 site-berichtete Ereignisse in der restriktiven und 49 in der liberalen Gruppe. Gesamtrate: 0,51 vs. 2,80 pro 100 Patient:innen; Ratenunterschied −2,29 (95 %-KI −3,12 bis −1,44).
Schlussfolgerung der Autor:innen
Die Rate schwerer TRAE war niedrig, aber in der liberalen Gruppe proportional zur Zahl transfundierter RBC-Einheiten erhöht. Der höhere Rate in der liberalen Gruppe reichte nicht aus, um die höheren 30-Tage-Raten von Myokardinfarkt oder Tod in der restriktiven Gruppe auszugleichen.
Kernaussagen
- Gesamtrate: 0,51 vs. 2,80 pro 100 Patient:innen
- Schwere TRAE: 0,51 vs. 1,99 pro 100 Patient:innen
- Per 100 RBC-Einheiten war der Unterschied für schwere TRAE nicht signifikant
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Transfusion, online erschienen am 26.11.2025. Verfasst von Shahab Ghafghazi und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Cardiology, University of Louisville, Louisville, Kentucky, USA. Hauptthemen laut MEDLINE: Transfusion Reaction, Myocardial Infarction, Erythrocyte Transfusion, Blood Transfusion. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, Canadian Blood Services and Canadian Institutes of Health Research (CIHR) Institute of Circulatory and Respiratory Health, National Heart, Lung, and Blood Institute.
Themen: Patientensicherheit
Abstract (Originalsprache)
Background
The aim of this analysis was to quantify and compare the frequency of transfusion‐related adverse events ( TRAE ) in adult patients with myocardial infarction transfused with a restrictive versus liberal transfusion strategy from the Myocardial Ischemia and Transfusion ( MINT ) trial. Study Design and Methods Clinical sites reported TRAE . Major TRAE were transfusion‐related acute lung injury, transfusion‐associated circulatory overload, acute hemolytic transfusion reaction, anaphylactic transfusion reaction, and transfusion‐associated sepsis. TRAE rates per transfusion arm per patient and per 100 units of red blood cells ( RBC) transfused were calculated.
Results
There were nine site‐reported events in the restrictive transfusion arm and 49 events in the liberal transfusion arm with an overall event rate of 0.51 in the restrictive transfusion arm, and 2.80 in the liberal transfusion arm per 100 patients, rate difference ‐2.29; 95% confidence interval [CI], ‐3.12,‐1.44.. The rate of major TRAE was 0.51 in the restrictive arm and 1.99 in the liberal arm per 100 patients, rate difference −1.48 (95% CI , −2.21, −0.74). When the rates were normalized per 100 units of RBC transfused, the rate difference of major TRAE was −0.08 (95% CI , −0.63, 0.46) and rate ratio was 0.90 (95% CI , 0.43, 1.87).
Conclusion
The rate of major TRAE was low, albeit increased in the liberal transfusion arm proportional to the number of RBC units transfused. The higher rate of major TRAE in the liberal arm was not sufficient to offset the increased rates of myocardial infarction or death at 30 days observed in patients assigned to the restrictive transfusion arm.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Division of Cardiology, University of Louisville, Louisville, Kentucky, USA.
- Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
- Harvard Medical School, Boston, Massachusetts, USA.
- Department of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Department of Biostatistics, School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Lynne Uhl, Marnie Bertolet, Jay Raval, Pedro Beraldo de Andrade, Robert O Roswell, Jeffrey L Carson
Förderung
- NHLBI NIH HHS
- Canadian Blood Services and Canadian Institutes of Health Research (CIHR) Institute of Circulatory and Respiratory Health
- National Heart, Lung, and Blood Institute
- Canadian Institutes of Health Research
Zitieren
APA
Ghafghazi, S., Uhl, L., Herbert, B., Bertolet, M., Alexander, J. H., Goodman, S. G., Raval, J., Roubille, F., Fordyce, C. B., Goldfarb, M., Bainey, K., de Andrade, P. B., Senaratne, J., Bracey, A., Roswell, R. O., Lopes, R., Simon, T., Steg, G., Brooks, M. M., …, & MINT Trial Investigators (2026). Transfusion‐related adverse events in patients with restrictive or liberal transfusion strategy. An analysis of the MINT trial. Transfusion, 66(1), 84-93. https://doi.org/10.1111/trf.70006
Vancouver
Ghafghazi S, Uhl L, Herbert B, Bertolet M, Alexander JH, Goodman SG, et al. Transfusion‐related adverse events in patients with restrictive or liberal transfusion strategy. An analysis of the MINT trial. Transfusion. 2026;66(1):84-93. doi:10.1111/trf.70006
BibTeX
@article{Ghafghazi2026,
author = {Ghafghazi, Shahab and Uhl, Lynne and Herbert, Brandon and Bertolet, Marnie and Alexander, John H and Goodman, Shaun G and Raval, Jay and Roubille, Francois and Fordyce, Christopher B and Goldfarb, Michael and Bainey, Kevin and de Andrade, Pedro Beraldo and Senaratne, Janek and Bracey, Arthur and Roswell, Robert O and Lopes, Renato and Simon, Tabassome and Steg, Gabriel and Brooks, Maria M and Hebert, Paul C and Carson, Jeffrey L and Triulizi, Darrell J and MINT Trial Investigators, MINT Trial Investigators},
title = {Transfusion‐related adverse events in patients with restrictive or liberal transfusion strategy. An analysis of the MINT trial},
journal = {Transfusion},
year = {2026},
volume = {66},
number = {1},
pages = {84--93},
doi = {10.1111/trf.70006}
}
EUVIMED